Arianna Marini

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Ebola virus and Sudan virus infection in humans: a comparison to inform vaccine research and development.

Ebola virus and Sudan virus infection in humans: a comparison to inform vaccine research and development.

Journal: Emerging microbes & infections

Published: July 10, 2026

Development and Qualification of a VSV-N IgG ELISA to Assess Vector-Directed Humoral Immunity in VSV-Vectored Vaccine Studies.

Development and Qualification of a VSV-N IgG ELISA to Assess Vector-Directed Humoral Immunity in VSV-Vectored Vaccine Studies.

Journal: Vaccines

Published: May 19, 2026

Development and qualification of an enzyme-linked immunosorbent assay to detect human serum immunoglobulin G reactive to multiple lineages of Lassa virus nucleoprotein.

Development and qualification of an enzyme-linked immunosorbent assay to detect human serum immunoglobulin G reactive to multiple lineages of Lassa virus nucleoprotein.

Journal: PloS one

Published: December 22, 2025

Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.

Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.

Journal: The New England journal of medicine

Published: November 05, 2025

Sudan virus disease in humans.

Sudan virus disease in humans.

Journal: The Lancet. Global health

Published: August 19, 2025

Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system.

Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system.

Journal: Vaccine

Published: September 18, 2023

Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies.

Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies.

Journal: Nature communications

Published: May 24, 2022

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly.

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly.

Journal: JCI insight

Published: October 05, 2021

Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans.

Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans.

Journal: Frontiers in immunology

Published: June 29, 2021

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.

Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.

Journal: Frontiers in immunology

Published: April 13, 2021

A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response.

A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response.

Journal: Frontiers in immunology

Published: September 25, 2019

Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice.

Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice.

Journal: Frontiers in immunology

Published: August 31, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026